Contract Manufacturing

Lonza leader outlines small-molecule trends for 2021 and beyond

06-May-2021 By Jenni Spinner

The head of small-molecule business for the pharma solutions specialist talks about obstacles, and how companies can work to clear them for future success.

PRA expands COVID-19 pharmacovigilance resources

04-May-2021 By Jenni Spinner

The CRO is offering an expanded range of post-authorization solutions designed to help developers with treatments and vaccines in their product pipeline

Explore vital drug delivery innovations at online event

03-May-2021 By Jenni Spinner

On May 5, a panel of experienced industry experts will discuss recent developments during Innovations in Drug Delivery, a free one-hour industry webinar.

CPhI survey: pharma leaders optimistic about the future

03-May-2021 By Jenni Spinner

According to a recent survey of executives conducted by CPhI, COVID-19’s impact is driving manufacturing and CDMOs are fueling industry growth.

CPhI: expect surge in IND applications, FDA approvals by 2025

23-Mar-2021 By Jenni Spinner

A new report from the organization forecasts a wave of pharma innovation over the next four years could lead to 75 FDA drug approvals annually by 2025.

IQVIA announces growth in Orchestrated Customer Engagement solution

15-Mar-2021 By Jenni Spinner

The Orchestrated Customer Engagement Technology reportedly has been adopted by 140 life sciences companies (including top-10 pharma firms) in nearly 90.

Lonza expands solid-form services at Oregon facility

01-Mar-2021 By Jenni Spinner

The company has increased capabilities at its Bend, Oregon location, including its SimpliFiH Solutions first-in-human services for small-molecule drugs.

Covectra launches StellaGuard ‘smart’ label anti-counterfeiting

22-Feb-2021 By Jenni Spinner

The on-pack technology enables consumers, retailers and others to harness mobile devices in order to verify the authenticity of pharmaceutical products.

On-demand capabilities help drug developers in a pinch

18-Feb-2021 By Jenni Spinner

With demand for fast-tracking therapies, vaccines and other products increasing, companies like Azzur Group offer the ability to add capabilities quickly.

Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies

18-Feb-2021 By Jane Byrne

Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and manufacturing organization (CDMO).

PwC joins Medicines Manufacturing Innovation Centre

11-Feb-2021 By Jenni Spinner

The global professional services firm has signed on the newest partner in the collaboration, aimed toward promoting innovation in pharma manufacturing.

WuXi STA to buy Bristol Myers Squibb’s Couvet, Switzerland manufacturing facility

02-Feb-2021 By Rachel Arthur

WuXi STA will purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland: giving the CDMO its first facility in Europe.

‘Cognitive’ supply chain approach boosts safety, efficiency: FourKites

21-Jan-2021 By Jenni Spinner

A leader from the supply-chain specialist explains vulnerabilities and challenges unique to pharma, and how professionals can safeguard and streamline.

Continuus lands $69.3m US drug manufacturing contract

21-Jan-2021 By Jenni Spinner

The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines for a range of conditions.

Fight against pharma counterfeiting must go deeper: TruTag

13-Jan-2021 By Jenni Spinner

A leader from the anti-counterfeit solutions firm says that while packaging-level efforts may have an effect, on-dose technology is worth a closer look.